Loading
Lipigon Pharmaceuticals AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 21 May 2025.
Lipigon Pharmaceuticals AB: what insiders have been doing
Lipigon Pharmaceuticals AB is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. Lipigon Pharmaceuticals AB has had no insider filing for more than a year; the last one goes back to 27 May 2025.
Over the whole record (from 2025), the tally stands at 2 purchases and no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
3
Thresholds
n/a
Buy Volume
€19,733
2 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJohan Living1 buy
Lars Öhman1 buy
Since the insiders bought
- +66.5%Entry SEK 0.10 · Close at T+90 SEK 0.16
- +66.5%Entry SEK 0.10 · Close at T+90 SEK 0.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 0.00
Analyst consensus
1 analystsSEK 0.01Target SEK 0.01(+567%)SEK 0.01
Income statement
EBITDA-SEK 32M
Net income-SEK 32.4M0.0% margin
Valuation
P/Book0.1x
Beta0.13
Balance sheet & cash
Market capSEK 908.9k
Free Cash Flow-SEK 35.9M
Profitability & ownership
ROE-413.9%
ROA-152.0%
% insiders36.4%
% institutions7.9%
Last declaration on 27 May 2025
Declarations3 total
15,120,000 shares@ SEK 0.09100.0% of flowBTA (betald tecknad aktie)ISIN SE0017911613FI:A003O967-1
728,000 shares@ SEK 0.097.38% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0017911613FI:A003O678-1
Canonical exit: 19 Aug 2025 (T+90)
1,652,000 shares@ SEK 0.0916.75% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0017911613FI:A003O661-2
Canonical exit: 19 Aug 2025 (T+90)
3 of 3 declarations
About Lipigon Pharmaceuticals AB
Lipigon Pharmaceuticals AB is a biopharmaceutical company focused on developing treatments for metabolic diseases. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
